Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Zyil-1
2. Zyil1
1. Zyil1
2. Zyil-1
3. Schembl22230951
4. (1e)-2-[(2r)-1,2-dimethyl-2-pyrrolidinyl]-n-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]ethenesulfonamide
5. 2455519-86-3
6. Ethenesulfonamide, 2-[(2r)-1,2-dimethyl-2-pyrrolidinyl]-n-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-, (1e)-
| Molecular Weight | 403.5 g/mol |
|---|---|
| Molecular Formula | C21H29N3O3S |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 86.9 |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 712 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
44
PharmaCompass offers a list of ZYIL1 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right ZYIL1 manufacturer or ZYIL1 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred ZYIL1 manufacturer or ZYIL1 supplier.
PharmaCompass also assists you with knowing the ZYIL1 API Price utilized in the formulation of products. ZYIL1 API Price is not always fixed or binding as the ZYIL1 Price is obtained through a variety of data sources. The ZYIL1 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Usnoflast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Usnoflast, including repackagers and relabelers. The FDA regulates Usnoflast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Usnoflast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Usnoflast supplier is an individual or a company that provides Usnoflast active pharmaceutical ingredient (API) or Usnoflast finished formulations upon request. The Usnoflast suppliers may include Usnoflast API manufacturers, exporters, distributors and traders.
Usnoflast Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Usnoflast GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Usnoflast GMP manufacturer or Usnoflast GMP API supplier for your needs.
A Usnoflast CoA (Certificate of Analysis) is a formal document that attests to Usnoflast's compliance with Usnoflast specifications and serves as a tool for batch-level quality control.
Usnoflast CoA mostly includes findings from lab analyses of a specific batch. For each Usnoflast CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Usnoflast may be tested according to a variety of international standards, such as European Pharmacopoeia (Usnoflast EP), Usnoflast JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Usnoflast USP).
